Chronic obstructive pulmonary disease (COPD) is characterized by symptoms of cough,
sputum and breathlessness, which become worse during acute exacerbations. The airway …

Background The role of inhaled corticosteroids (ICS) in chronic obstructive pulmonary
disease (COPD) has been the subject of much controversy. Major international guidelines …

Background The role of inhaled corticosteroids (ICS) in chronic obstructive pulmonary
disease (COPD) has been the subject of much uncertainty. COPD clinical guidelines …

PURPOSE: Although inhaled corticosteroids are commonly used to treat patients with
chronic obstructive pulmonary disease (COPD), their effect on clinical outcomes such as …

Background Current guidelines recommend that patients with acute exacerbations of
chronic obstructive pulmonary disease (COPD) should be treated with systemic …

The effectiveness of inhaled corticosteroids (ICS) in patients with chronic obstructive
pulmonary disease (COPD) remains controversial. Randomized controlled trials, meta …

Background Systemic corticosteroids (SCS) have been shown to improve the outcome of
acute exacerbation of chronic obstructive pulmonary disease (AECOPD). However, the …

Background: Several clinical trials have evaluated the benefits associated with adding an
inhaled corticosteroid (ICS) to a long-acting bronchodilator in the treatment of severe or very …

Chronic obstructive pulmonary disease (COPD) is an increasingly important public health
problem. It remains one of the leading causes of disability in developed countries and is …

Background Chronic obstructive pulmonary disease (COPD) is a chronic and progressive
disease that affects an estimated 10% of the world's population over the age of 40 years …